{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:26:51Z","timestamp":1787016411354,"version":"build-2736575974"},"reference-count":58,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1124\/jpet.124.002273","type":"journal-article","created":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T01:14:23Z","timestamp":1724634863000},"page":"100030","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Inhibition of TTX-S Na+ currents by a novel blocker QLS-278 for antinociception"],"prefix":"10.1016","volume":"392","author":[{"given":"Min","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangshuo","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liying","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liming","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7023-9998","authenticated-orcid":false,"given":"KeWei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5675-4712","authenticated-orcid":false,"given":"Yani","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.124.002273_bib1","doi-asserted-by":"crossref","DOI":"10.1126\/science.aac5464","article-title":"Structural basis of Nav1.7 inhibition by an isoform-selective small-molecule antagonist","volume":"350","author":"Ahuja","year":"2015","journal-title":"Science"},{"key":"10.1124\/jpet.124.002273_bib2","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1016\/j.celrep.2018.08.063","article-title":"Selective NaV1.7 antagonists with long residence time show improved efficacy against inflammatory and neuropathic pain","volume":"24","author":"Bankar","year":"2018","journal-title":"Cell Rep"},{"key":"10.1124\/jpet.124.002273_bib3","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1152\/physrev.00052.2017","article-title":"The role of voltage-gated sodium channels in pain signaling","volume":"99","author":"Bennett","year":"2019","journal-title":"Physiol Rev"},{"key":"10.1124\/jpet.124.002273_bib4","doi-asserted-by":"crossref","first-page":"14.e11","DOI":"10.1016\/j.pain.2005.10.036","article-title":"Assessment and analysis of mechanical allodynia-like behavior induced by spared nerve injury (SNI) in the mouse","volume":"122","author":"Bourquin","year":"2006","journal-title":"Pain"},{"key":"10.1124\/jpet.124.002273_bib5","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1097\/j.pain.0000000000001807","article-title":"Pharmacological characterization of a rat Nav1.7 loss-of-function model with insensitivity to pain","volume":"161","author":"Chen","year":"2020","journal-title":"Pain"},{"key":"10.1124\/jpet.124.002273_bib6","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1093\/brain\/awaa208","article-title":"Sodium channel Nav1.6 in sensory neurons contributes to vincristine-induced allodynia","volume":"143","author":"Chen","year":"2020","journal-title":"Brain"},{"key":"10.1124\/jpet.124.002273_bib7","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/nature05413","article-title":"An SCN9A channelopathy causes congenital inability to experience pain","volume":"444","author":"Cox","year":"2006","journal-title":"Nature"},{"key":"10.1124\/jpet.124.002273_bib8","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/ana.10364","article-title":"Changes of sodium channel expression in experimental painful diabetic neuropathy","volume":"52","author":"Craner","year":"2002","journal-title":"Ann Neurol"},{"key":"10.1124\/jpet.124.002273_bib9","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1016\/j.neuron.2023.05.024","article-title":"Nav1.7 is essential for nociceptor action potentials in the mouse in a manner independent of endogenous opioids","volume":"111","author":"Deng","year":"2023","journal-title":"Neuron"},{"key":"10.1124\/jpet.124.002273_bib10","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3390\/toxins8030078","article-title":"Analgesic effects of GpTx-1, PF-04856264 and CNV1014802 in a mouse model of NaV1.7-mediated pain","volume":"8","author":"Deuis","year":"2016","journal-title":"Toxins (Basel)"},{"issue":"Suppl 1","key":"10.1124\/jpet.124.002273_bib11","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1097\/j.pain.0000000000000854","article-title":"Sodium channels in pain disorders: pathophysiology and prospects for treatment","volume":"158","author":"Dib-Hajj","year":"2017","journal-title":"Pain"},{"key":"10.1124\/jpet.124.002273_bib12","first-page":"1487","article-title":"A\u00a0review of the therapeutic targeting of SCN9A and Nav1.7 for pain relief in current human clinical trials","volume":"16","author":"Dormer","year":"2023","journal-title":"J\u00a0Pain Res"},{"key":"10.1124\/jpet.124.002273_bib13","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/ana.22485","article-title":"Gain of function NaV1.7 mutations in idiopathic small fiber neuropathy","volume":"71","author":"Faber","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1124\/jpet.124.002273_bib14","doi-asserted-by":"crossref","first-page":"19444","DOI":"10.1073\/pnas.1216080109","article-title":"Gain-of-function Nav1.8 mutations in painful neuropathy","volume":"109","author":"Faber","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1124\/jpet.124.002273_bib15","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.neuron.2006.10.006","article-title":"SCN9A mutations in paroxysmal extreme pain disorder: allelic variants underlie distinct channel defects and phenotypes","volume":"52","author":"Fertleman","year":"2006","journal-title":"Neuron"},{"key":"10.1124\/jpet.124.002273_bib16","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/bs.ctm.2016.04.001","article-title":"Physiology and pathophysiology of sodium channel inactivation","volume":"78","author":"Ghovanloo","year":"2016","journal-title":"Curr Top Membr"},{"key":"10.1124\/jpet.124.002273_bib17","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/s41583-021-00444-w","article-title":"The physiological function of different voltage-gated sodium channels in pain","volume":"22","author":"Goodwin","year":"2021","journal-title":"Nat Rev Neurosci"},{"key":"10.1124\/jpet.124.002273_bib18","doi-asserted-by":"crossref","first-page":"8881","DOI":"10.1523\/JNEUROSCI.23-26-08881.2003","article-title":"Upregulation of sodium channel Nav1.3 and functional involvement in neuronal hyperexcitability associated with central neuropathic pain after spinal cord injury","volume":"23","author":"Hains","year":"2003","journal-title":"J\u00a0Neurosci"},{"key":"10.1124\/jpet.124.002273_bib19","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1136\/jnnp-2013-306095","article-title":"The G1662S NaV1.8 mutation in small fibre neuropathy: impaired inactivation underlying DRG neuron hyperexcitability","volume":"85","author":"Han","year":"2014","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1124\/jpet.124.002273_bib20","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.brainres.2017.01.011","article-title":"Dissociation of morphine analgesic effects in the sensory and affective components of formalin-induced spontaneous pain in male and female rats","volume":"1658","author":"Harton","year":"2017","journal-title":"Brain Res"},{"key":"10.1124\/jpet.124.002273_bib21","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1038\/s41467-023-39307-6","article-title":"Cannabidiol inhibits Nav channels through two distinct binding sites","volume":"14","author":"Huang","year":"2023","journal-title":"Nat Commun"},{"key":"10.1124\/jpet.124.002273_bib22","doi-asserted-by":"crossref","first-page":"12328","DOI":"10.1523\/JNEUROSCI.2773-14.2014","article-title":"Depolarized inactivation overcomes impaired activation to produce DRG neuron hyperexcitability in a Nav1.7 mutation in a patient with distal limb pain","volume":"34","author":"Huang","year":"2014","journal-title":"J\u00a0Neurosci"},{"key":"10.1124\/jpet.124.002273_bib23","article-title":"Dual-pocket inhibition of Nav channels by the antiepileptic drug lamotrigine","volume":"120","author":"Huanga","year":"2023","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1124\/jpet.124.002273_bib24","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aah4874","article-title":"Synergistic regulation of serotonin and opioid signaling contributes to pain insensitivity in Nav1.7 knockout mice","volume":"10","author":"Isensee","year":"2017","journal-title":"Sci Signal"},{"key":"10.1124\/jpet.124.002273_bib25","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.cell.2019.11.041","article-title":"Structure of the cardiac sodium channel","volume":"180","author":"Jiang","year":"2020","journal-title":"Cell"},{"key":"10.1124\/jpet.124.002273_bib26","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1039\/D2MD00081D","article-title":"Inhibition of NaV1.7: the possibility of ideal analgesics","volume":"13","author":"Kitano","year":"2022","journal-title":"RSC Med Chem"},{"key":"10.1124\/jpet.124.002273_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121520","article-title":"NAN-190, a 5-HT1A antagonist, alleviates inflammatory pain by targeting Nav1.7 sodium channels","volume":"319","author":"Li","year":"2023","journal-title":"Life Sci"},{"key":"10.1124\/jpet.124.002273_bib28","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.pain.2005.05.027","article-title":"Relationship between sodium channel NaV1.3 expression and neuropathic pain behavior in rats","volume":"117","author":"Lindia","year":"2005","journal-title":"Pain"},{"key":"10.1124\/jpet.124.002273_bib29","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/164_2019_333","article-title":"Exploiting the diversity of ion channels: modulation of ion channels for therapeutic indications","volume":"260","author":"Liu","year":"2019","journal-title":"Handb Exp Pharmacol"},{"key":"10.1124\/jpet.124.002273_bib30","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.neuron.2019.01.047","article-title":"Defining the functional role of NaV1.7 in human nociception","volume":"101","author":"McDermott","year":"2019","journal-title":"Neuron"},{"key":"10.1124\/jpet.124.002273_bib31","article-title":"Global Nav1.7 knockout mice recapitulate the phenotype of human congenital indifference to pain","volume":"9","author":"McKemy","year":"2014","journal-title":"PLoS One"},{"key":"10.1124\/jpet.124.002273_bib32","doi-asserted-by":"crossref","first-page":"13525","DOI":"10.1073\/pnas.0705924104","article-title":"TRPA1 mediates formalin-induced pain","volume":"104","author":"McNamara","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1124\/jpet.124.002273_bib33","doi-asserted-by":"crossref","first-page":"8967","DOI":"10.1038\/ncomms9967","article-title":"Endogenous opioids contribute to insensitivity to pain in humans and mice lacking sodium channel Nav1.7","volume":"6","author":"Minett","year":"2015","journal-title":"Nat Commun"},{"key":"10.1124\/jpet.124.002273_bib34","first-page":"556","article-title":"Systemic toxicity and cardiotoxicity from local anesthetics: incidence and preventive measures","volume":"27","author":"Mulroy","year":"2002","journal-title":"Reg Anesth Pain Med"},{"key":"10.1124\/jpet.124.002273_bib35","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/s41401-021-00682-9","article-title":"Inhibition of Nav1.7 channel by a novel blocker QLS-81 for alleviation of neuropathic pain","volume":"42","author":"Niu","year":"2021","journal-title":"Acta Pharmacol Sin"},{"key":"10.1124\/jpet.124.002273_bib36","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/320188a0","article-title":"Existence of distinct sodium channel messenger RNAs in rat brain","volume":"320","author":"Noda","year":"1986","journal-title":"Nature"},{"key":"10.1124\/jpet.124.002273_bib37","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/164_2017_73","article-title":"Mechanisms of drug binding to voltage-gated sodium channels","volume":"246","author":"O\u2019Leary","year":"2018","journal-title":"Handb Exp Pharmacol"},{"key":"10.1124\/jpet.124.002273_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2023.117290","article-title":"Design, synthesis, and biological evaluation of acyl sulfonamide derivatives with spiro cycles as NaV1.7 inhibitors for antinociception","volume":"86","author":"Ouyang","year":"2023","journal-title":"Bioorg Med Chem"},{"key":"10.1124\/jpet.124.002273_bib39","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.vascn.2004.08.007","article-title":"Dorsal root ganglion neurones in culture: a model system for identifying novel analgesic targets?","volume":"51","author":"Passmore","year":"2005","journal-title":"J\u00a0Pharmacol Toxicol Methods"},{"key":"10.1124\/jpet.124.002273_bib40","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nature10238","article-title":"The crystal structure of a voltage-gated sodium channel","volume":"475","author":"Payandeh","year":"2011","journal-title":"Nature"},{"key":"10.1124\/jpet.124.002273_bib41","article-title":"Subtype-selective small molecule inhibitors reveal a fundamental role for Nav1.7 in nociceptor electrogenesis, axonal conduction and presynaptic release","volume":"11","author":"Price","year":"2016","journal-title":"PLoS One"},{"key":"10.1124\/jpet.124.002273_bib42","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1126\/science.8085162","article-title":"Molecular determinants of state-dependent block of Na+ channels by local anesthetics","volume":"265","author":"Ragsdale","year":"1994","journal-title":"Science"},{"key":"10.1124\/jpet.124.002273_bib43","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1021\/acs.jmedchem.1c00049","article-title":"Discovery of acyl-sulfonamide Nav1.7 inhibitors GDC-0276 and GDC-0310","volume":"64","author":"Safina","year":"2021","journal-title":"J\u00a0Med Chem"},{"key":"10.1124\/jpet.124.002273_bib44","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1124\/mol.108.047670","article-title":"ProTx-II, a selective inhibitor of NaV1.7 sodium channels, blocks action potential propagation in nociceptors","volume":"74","author":"Schmalhofer","year":"2008","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.124.002273_bib45","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.toxlet.2023.07.010","article-title":"MAPK-ERK-CREB signaling pathway upregulates Nav1.6 in oxaliplatin-induced neuropathic pain in the rat","volume":"384","author":"Shao","year":"2023","journal-title":"Toxicol Lett"},{"key":"10.1124\/jpet.124.002273_bib46","doi-asserted-by":"crossref","first-page":"10180","DOI":"10.1523\/JNEUROSCI.1049-18.2018","article-title":"Insensitivity to pain upon adult-onset deletion of Nav1.7 or its blockade with selective inhibitors","volume":"38","author":"Shields","year":"2018","journal-title":"J\u00a0Neurosci"},{"key":"10.1124\/jpet.124.002273_bib47","series-title":"StatPearls","article-title":"Mexiletine","author":"Singh","year":"2023"},{"key":"10.1124\/jpet.124.002273_bib48","doi-asserted-by":"crossref","first-page":"12687","DOI":"10.1074\/jbc.M610462200","article-title":"Molecular interactions of the gating modifier toxin ProTx-II with NaV1.5: implied existence of a novel toxin binding site coupled to activation","volume":"282","author":"Smith","year":"2007","journal-title":"J\u00a0Biol Chem"},{"key":"10.1124\/jpet.124.002273_bib49","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3389\/fphar.2011.00054","article-title":"Recent developments regarding voltage-gated sodium channel blockers for the treatment of inherited and acquired neuropathic pain syndromes","volume":"2","author":"Theile","year":"2011","journal-title":"Front Pharmacol"},{"key":"10.1124\/jpet.124.002273_bib50","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.molmed.2005.10.004","article-title":"Erythermalgia: molecular basis for an inherited pain syndrome","volume":"11","author":"Waxman","year":"2005","journal-title":"Trends Mol Med"},{"key":"10.1124\/jpet.124.002273_bib51","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1038\/s41467-023-38942-3","article-title":"Structural mapping of Nav1.7 antagonists","volume":"14","author":"Wu","year":"2023","journal-title":"Nat Commun"},{"key":"10.1124\/jpet.124.002273_bib52","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.brainres.2004.09.051","article-title":"Tetrodotoxin-sensitive and -resistant Na+ channel currents in subsets of small sensory neurons of rats","volume":"1029","author":"Wu","year":"2004","journal-title":"Brain Res"},{"key":"10.1124\/jpet.124.002273_bib53","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.cell.2018.12.018","article-title":"Structural basis of Nav1.7 inhibition by a gating-modifier spider toxin","volume":"176","author":"Xu","year":"2019","journal-title":"Cell"},{"key":"10.1124\/jpet.124.002273_bib54","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.drudis.2019.05.014","article-title":"Voltage-gated sodium channels: structures, functions, and molecular modeling","volume":"24","author":"Xu","year":"2019","journal-title":"Drug Discov Today"},{"key":"10.1124\/jpet.124.002273_bib55","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.cclet.2021.08.026","article-title":"Design and synthesis of novel \u03b1-aminoamides derivatives as Nav1.7 inhibitors for antinociception","volume":"33","author":"Xue","year":"2022","journal-title":"Chin Chem Lett"},{"key":"10.1124\/jpet.124.002273_bib56","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1136\/jmg.2003.012153","article-title":"Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia","volume":"41","author":"Yang","year":"2004","journal-title":"J\u00a0Med Genet"},{"key":"10.1124\/jpet.124.002273_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100326","article-title":"Engineering of highly potent and selective HNTX-III mutant against hNav1.7 sodium channel for treatment of pain","volume":"296","author":"Zhang","year":"2021","journal-title":"J\u00a0Biol Chem"},{"key":"10.1124\/jpet.124.002273_bib58","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/aps.2017.151","article-title":"Enhancing inactivation rather than reducing activation of Nav1.7 channels by a clinically effective analgesic CNV1014802","volume":"39","author":"Zheng","year":"2018","journal-title":"Acta Pharmacol Sin"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524000880?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524000880?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.124.002273","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T16:56:10Z","timestamp":1742230570000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524000880"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":58,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S0022356524000880"],"URL":"https:\/\/doi.org\/10.1124\/jpet.124.002273","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of TTX-S Na+ currents by a novel blocker QLS-278 for antinociception","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.124.002273","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jpet.2024.100037","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"100030"}}